Steris (STE) Non-Current Deferred Tax Liability (2018 - 2026)
Steris (STE) recorded quarterly Non-Current Deferred Tax Liability of $390.7 million in Q1 2026, down 5.74% quarter-over-quarter from $414.5 million in Q4 2025, and down 3.22% on a YoY basis from $403.7 million in Q1 2025.
Steris (STE) Non-Current Deferred Tax Liability (2018 - 2026) Analysis & Trends
Steris' Non-Current Deferred Tax Liability history runs 9 years deep, the most recent figure standing at $390.7 million for Q1 2026.
- In Q1 2026, Non-Current Deferred Tax Liability fell 3.22% year-over-year to $390.7 million; the TTM figure through Mar 2026 stood at $390.7 million (down 3.22% YoY), while the FY2026 annual figure was $390.7 million, down 3.22% from the prior year.
- Non-Current Deferred Tax Liability was $390.7 million for Q1 2026 at Steris, down from $414.5 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $790.8 million in Q2 2022 to a low of $390.7 million in Q1 2026.
- Historically, Non-Current Deferred Tax Liability has averaged $550.6 million across 5 years, with a median of $479.7 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Non-Current Deferred Tax Liability soared 229.57% in 2022, then fell 27.04% in 2024.
- A 5-year view of Non-Current Deferred Tax Liability shows it stood at $724.6 million in 2022, then dropped by 14.29% to $621.1 million in 2023, then dropped by 27.04% to $453.1 million in 2024, then retreated by 8.52% to $414.5 million in 2025, then dropped by 5.74% to $390.7 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $390.7 million (Q1 2026), $414.5 million (Q4 2025), and $412.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 390.70 Mn |
| Mar 31, 2026 | 390.70 Mn |
| Dec 31, 2025 | 414.50 Mn |
| Dec 31, 2025 | 414.50 Mn |
| Sep 30, 2025 | 412.00 Mn |
| Sep 30, 2025 | 412.00 Mn |
| Jun 30, 2025 | 411.40 Mn |
| Jun 30, 2025 | 411.40 Mn |
| Mar 31, 2025 | 403.70 Mn |
| Mar 31, 2025 | 403.70 Mn |
| Dec 31, 2024 | 453.13 Mn |
| Dec 31, 2024 | 453.13 Mn |
| Sep 30, 2024 | 462.74 Mn |
| Sep 30, 2024 | 462.74 Mn |
| Jun 30, 2024 | 456.47 Mn |
| Jun 30, 2024 | 456.47 Mn |
| Mar 31, 2024 | 479.69 Mn |
| Mar 31, 2024 | 479.69 Mn |
| Dec 31, 2023 | 621.07 Mn |
| Dec 31, 2023 | 621.07 Mn |